Huber; Florian Anton Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huber; Florian Anton Martin.The latest application filed is for "process for preparation of 2,2-dimethylpiperazine".

Company Profile

4.16.16

Huber; Florian Anton Martin - Dolo VE IT
Huber; Florian Anton Martin - Dollo VE IT
Huber; Florian Anton Martin - Dolo IT
HUBER; Florian Anton Martin - Dolo Venezia
Huber; Florian Anton Martin - Venice IT
Huber; Florian Anton Martin - Bolzano Vicentino IT
Huber; Florian Anton Martin - Bozen N/A IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol Grant 11,332,478 - De Faveri , et al. May 17, 2	2022-05-17
Process For Preparation Of 2,2-dimethylpiperazine App 20210147366 - De Faveri; Carla ; et al.	2021-05-20
Manufacture Of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol App 20200223865 - De Faveri; Carla ; et al.	2020-07-16
Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol Grant 10,626,123 - De Faveri , et al.	2020-04-21
Process intermediates and methods for the preparation of process intermediates for the synthesis of argatroban monohydrate Grant 10,385,020 - Stivanello , et al. A	2019-08-20
Process for the preparation of isocarboxazid Grant 10,329,264 - De Faveri , et al.	2019-06-25
Process Intermediates And Methods For The Preparation Of Process Intermediates For The Synthesis Of Argatroban Monohydrate App 20180258041 - Stivanello; Mariano ; et al.	2018-09-13
Process For The Preparation Of Isocarboxazid App 20180215722 - De Faveri; Carla ; et al.	2018-08-02
Process intermediates and methods for the preparation of process intermediates for the synthesis of argatroban monohydrate Grant 9,994,526 - Stivanello , et al. June 12, 2	2018-06-12
Process for the manufacture of idalopirdine via hydrogenation of an imine Grant 9,975,850 - Jacobsen , et al. May 22, 2	2018-05-22
Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol App 20180065984 - De Faveri; Carla ; et al.	2018-03-08
Process for the Manufacture of Idalopirdine via Hydrogenation of an Imine App 20170291874 - Jacobsen; Mikkel Fog ; et al.	2017-10-12
Process Intermediates And Methods For The Preparation Of Process Intermediates For The Synthesis Of Argatroban Monohydrate App 20160347711 - Stivanello; Mariano ; et al.	2016-12-01
Methods for preparing ritodrine hydrochloride Grant 8,912,360 - Zanon , et al. December 16, 2	2014-12-16
Nalmefene hydrochloride dihydrate Grant 8,754,217 - Lopez de Diego , et al. June 17, 2	2014-06-17
Method For The Manufacturing Of Naltrexone App 20140155608 - De Faveri; Carla ; et al.	2014-06-05
Process Intermediates And Methods For The Preparation Of Process Intermediates For The Synthesis Of Argatroban Monohydrate App 20140088310 - Stivanello; Mariano ; et al.	2014-03-27
Nalmefene Hydrochloride Dihydrate App 20130338365 - Lopez de DIEGO; Heidi ; et al.	2013-12-19
Method for the manufacturing of naltrexone Grant 8,580,963 - De Faveri , et al. November 12, 2	2013-11-12
Nalmefene hydrochloride dihydrate Grant 8,530,495 - Lopez de Diego , et al. September 10, 2	2013-09-10
Process for the manufacture of memantine and intermediate product Grant 8,436,209 - Huber , et al. May 7, 2	2013-05-07
Method For The Manufacturing Of Naltrexone App 20120116085 - De Faveri; Carla ; et al.	2012-05-10
Method For Producing Memantine App 20110288336 - Gold; Markus-Rene ; et al.	2011-11-24
Nalmefene Hydrochloride Dihydrate App 20110251228 - Lopez de Diego; Heidi ; et al.	2011-10-13
Method for manufacture of escitalopram Grant 8,022,232 - De Faveri , et al. September 20, 2	2011-09-20
Process For The Manufacture Of Memantine And Intermediate Product. App 20110082317 - Huber; Florian Anton Martin ; et al.	2011-04-07
Method For Manufacture Of Escitalopram App 20090069582 - De Faveri; Carla ; et al.	2009-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.